Intended for healthcare professionals

Rapid response to:


Sixty seconds on . . . covid booster vaccines

BMJ 2021; 374 doi: (Published 03 September 2021) Cite this as: BMJ 2021;374:n2179

Read our latest coverage of the coronavirus pandemic

Rapid Response:

To test, or not to test, that is the question

Dear Editor,

We have read the "sixty seconds" guidance with interest. As regards to testing for antibody levels against Covid-19, there is currently debatable information in relation to its usefulness as serological tests can vary in their individual performance characteristics (1).

Studies have explored the levels of spike glycoprotein IgG (IgG S-receptor). They have found that these may be correlated to immune response as a surrogate measure of antibody neutralization. Levels at or above 4,160 AU / ml (which correlates with a 95% probability of high neutralizing antibody titer) were observed in one study (2).

Furthermore, there has not been, to-date any solid guidance by the relevant international organizations i.e. CDC, FDA and WHO etc. The interim CDC guideline updated in March 2021 and the FDA Safety Communication issued on the 19th May 2021 both do not recommend antibody testing to assess for adequate immunity following covid-19 vaccination.

Although it is tempting to consider individuals as immune against Covid-19 when their antibody levels are exceedingly high, however until now there is no solid evidence that supports it. Therefore, in our view it would be prudent to give the booster without testing and even when the levels are known to be very high.

The answer to our title question is: not to test but boost … than "suffer the slings and arrows of outrageous fortune”.

1. Annapaola Callegaro Antibody response to SARS Cov-2 vaccination is extremely vivacious in subjects with previous SARS-2 Infection. Journal of Medical Virology 2021, July.
2. SARS Cov2 IgG2 Quantitative Assay User Manual (Abbott Laboratories Diagnostic Division 2020).

Competing interests: No competing interests

13 September 2021
Walid Al-Wali
Senior Consultant Medical Microbiologist/Vice-Chair of Clinical Pathology.
Dr Adeela Shaukat (Senior Consultant in Infectious Diseases, Al-Wakra Hospital), Dr Masautso Chaponda (Senior Consultant in Infectious Diseases, Al-Wakra Hospital), Ms Tahani Al-Saadi (Senior Medical Laboratory Scientist, Al-Wakra Hospital)
Department of Laboratory Medicine and Pathology, The Hamad Medical Corporation, State of Qatar.
Department of Clinical Microbiology, Al-Wakra Hospital, Al-Wakra, State of Qatar.